OFLX

In the past six months, Omega Flex reported lower year-over-year sales and net income for Q2 and the first half of 2026, with net sales decreasing by 3.5% to $47.2 million and net income falling by 38.5% to $4.8 million due to a weaker construction market and increased costs. Cash and cash equivalents also decreased by $5.3 million. Despite financial pressures, the company introduced a re-engineered TracPipe fitting in July 2026 and its MediTrac corrugated medical tubing received CE mark certification in August 2026, allowing for expanded sales in European medical markets. The stock price has decreased by 10.7% since the beginning of 2026, though the CFO purchased 1,000 shares in September 2026, contributing to a pattern of insider accumulation. Omega Flex also declared a regular quarterly dividend of $0.34 per share for Q3 2026.